Richardson P D, Withrington P G
Br J Pharmacol. 1978 Dec;64(4):581-8. doi: 10.1111/j.1476-5381.1978.tb17320.x.
1 The sympathetically-innervated hepatic arterial and portal venous vascular beds of the dog were perfused simultaneously in situ. 2 Histamine and 5-hydroxytryptamine (5-HT) were injected intra-arterially and intraportally in graded, increasing doses. 3 Intra-arterial histamine evoked decreases in hepatic arterial vascular resistance (HAVR) and increases in hepatic portal vascular resistance (HPVR). 4 Intraportal injections of histamine caused increases in HPVR and decreases in HAVR. 5 The time courses of the arterial responses to intraportal histamine and of the portal responses to intra-arterial histamine, compared with any systemic effects, showed that these effects on the liver vasculature could not be the result of recirculation of histamine. 6 Intra-arterial 5-HT evoked biphasic changes in HAVR and small falls in HPVR. Intraportal 5-HT caused falls in HPVR at low doses and rises at high doses, together, typically, with biphasic effects on HAVR. 7 It is unlikely that the arterial effects of intraportal 5-HT and the portal effects of intra-arterial 5-HT were due to recirculation of the vasoactive material. 8 Pathophysiologically, both histamine and 5-HT are released from the gastrointestinal tract into the portal vein. These experiments show that such release may affect the hepatic arterial vascular resistance (and therefore blood flow) even though vasoactive levels of the autacoids are not attained in the systemic circulation.
在原位同时对犬的受交感神经支配的肝动脉和门静脉血管床进行灌注。
组胺和5-羟色胺(5-HT)以递增的梯度剂量经动脉内和门静脉内注射。
动脉内注射组胺导致肝动脉血管阻力(HAVR)降低,肝门静脉血管阻力(HPVR)升高。
门静脉内注射组胺导致HPVR升高,HAVR降低。
与任何全身效应相比,门静脉内组胺引起的动脉反应和动脉内组胺引起的门静脉反应的时间进程表明,这些对肝脏血管系统的影响不可能是组胺再循环的结果。
动脉内注射5-HT引起HAVR的双相变化和HPVR的小幅下降。门静脉内注射5-HT在低剂量时导致HPVR下降,在高剂量时导致HPVR升高,通常同时对HAVR有双相影响。
门静脉内5-HT的动脉效应和动脉内5-HT的门静脉效应不太可能是由于血管活性物质的再循环。
在病理生理学上,组胺和5-HT都从胃肠道释放到门静脉中。这些实验表明,即使在全身循环中未达到自分泌物质的血管活性水平,这种释放也可能影响肝动脉血管阻力(进而影响血流)。